CXCL12 and cancer: In the bone marrow, the chemokine CXCL12 (i.e., stromal-derived factor-1) recruits hematopoietic stem cells through its interaction with CXCR4 receptor (CD184), and this axis can be hijacked by cancer cells [10,45].